Dose Adjustment Patterns in the Open-Label Extension Arms of Three Phase 3 Trials of Certolizumab Pegol in Psoriasis: CIMPASI-1, CIMPASI-2, and CIMPACT. J of Skin [Internet]. 2020 Oct. 27 [cited 2025 Apr. 19];4(6):s85. Available from: https://skin.dermsquared.com/skin/article/view/1118